Half Yearly Results Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
100.85
83.01
78.17
76.83
82.29
72.07
40.60
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
100.85
83.01
78.17
76.83
82.29
72.07
40.60
Raw Material Cost
45.98
38.54
39.36
39.63
40.99
31.43
21.04
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
4.02
0.74
-3.58
-1.06
0.22
-2.55
0.17
Employee Cost
14.40
12.77
10.88
8.32
7.64
6.24
5.80
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.01
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
18.39
14.95
14.90
11.39
8.56
7.87
6.45
Total Expenditure (Excl Depreciation)
82.79
67.00
61.57
58.28
57.41
42.99
33.46
Operating Profit (PBDIT) excl Other Income
18.06
16.01
16.60
18.55
24.88
29.08
7.14
Other Income
2.05
0.94
0.83
1.17
0.40
0.40
0.52
Operating Profit (PBDIT)
20.11
16.95
17.43
19.72
25.28
29.48
7.66
Interest
0.42
0.57
0.57
0.35
0.74
0.84
1.16
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.09
0.00
Gross Profit (PBDT)
19.69
16.38
16.86
19.37
24.54
28.73
6.50
Depreciation
2.36
2.14
1.66
1.24
1.21
0.92
0.89
Profit Before Tax
17.33
14.23
15.21
18.13
23.34
27.82
5.60
Tax
4.31
3.53
3.78
4.45
5.87
7.01
1.53
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
13.02
10.70
11.44
13.68
17.46
20.80
4.07
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
13.02
10.70
11.44
13.68
17.46
20.80
4.07
Share in Profit of Associates
1.60
2.39
1.24
2.95
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
-2.35
-0.85
-0.69
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
14.63
13.09
12.68
16.63
15.12
19.95
3.38
Equity Capital
8.26
8.26
8.26
8.26
8.26
8.26
8.26
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
74.37
0.00
0.00
Earnings per share (EPS)
17.71
15.85
15.35
20.13
18.31
24.15
4.09
Diluted Earnings per share
17.7
15.85
15.35
20.13
18.29
24.14
4.09
Operating Profit Margin (Excl OI)
17.91%
19.29%
21.24%
24.14%
30.23%
40.35%
17.59%
Gross Profit Margin
19.52%
19.73%
21.57%
25.21%
29.82%
39.86%
16.01%
PAT Margin
12.91%
12.89%
14.63%
17.81%
21.22%
28.86%
10.02%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 21.49% vs 6.19% in Sep 2024
Consolidate Net Profit
Growth in half year ended Sep 2025 is 11.76% vs 3.23% in Sep 2024
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is 12.80% vs -3.55% in Sep 2024
Interest
Growth in half year ended Sep 2025 is -26.32% vs 0.00% in Sep 2024
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has fallen from Sep 2024
Compare Half Yearly Results Of Titan Biotech With
Figures in Cr
Consolidate Half Yearly Results
Change(INR)
Change(%)
Net Sales
100.85
564.63
-463.78
-82.14%
Other Operating Income
0.00
0.00
0.00
Total Operating income
100.85
564.63
-463.78
-82.14%
Raw Material Cost
45.98
380.90
-334.92
-87.93%
Purchase of Finished goods
0.00
8.15
-8.15
-100.00%
(Increase) / Decrease In Stocks
4.02
-15.93
19.95
125.24%
Employee Cost
14.40
31.11
-16.71
-53.71%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
18.39
97.12
-78.73
-81.06%
Total Expenditure (Excl Depreciation)
82.79
501.35
-418.56
-83.49%
Operating Profit (PBDIT) excl Other Income
18.06
63.28
-45.22
-71.46%
Other Income
2.05
20.43
-18.38
-89.97%
Operating Profit (PBDIT)
20.11
83.71
-63.60
-75.98%
Interest
0.42
12.26
-11.84
-96.57%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
19.69
71.45
-51.76
-72.44%
Depreciation
2.36
10.31
-7.95
-77.11%
Profit Before Tax
17.33
61.14
-43.81
-71.66%
Tax
4.31
14.19
-9.88
-69.63%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
13.02
46.95
-33.93
-72.27%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
13.02
46.95
-33.93
-72.27%
Share in Profit of Associates
1.60
0.00
1.60
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
14.63
46.95
-32.32
-68.84%
Equity Capital
8.26
36.29
-28.03
-77.24%
Face Value
10.00
5.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
17.71
6.47
11.24
173.72%
Diluted Earnings per share
17.70
6.44
11.26
174.84%
Operating Profit Margin (Excl OI)
17.91%
11.21%
0.00
6.70%
Gross Profit Margin
19.52%
12.65%
0.00
6.87%
PAT Margin
12.91%
8.32%
0.00
4.59%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 100.85 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 21.49% vs 6.19% in Sep 2024
Half Yearly - Consolidate Net Profit
Consolidate Net Profit 14.63 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 11.76% vs 3.23% in Sep 2024
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18.06 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 12.80% vs -3.55% in Sep 2024
Half Yearly - Interest
Interest 0.42 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -26.32% vs 0.00% in Sep 2024
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.91%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has fallen from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
